Based on a systematic review and meta-analysis, high FSCN1 expression is associated with an increased risk of progression in colorectal, breast and esophageal cancer and with the presence of metastatic lesions in gastric and colorectal cancer [26]. The gene discussed is FSCN1; the disease is colorectal cancer.